0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Presidential Address | 
Ashby C. Moncure, MD
Arch Surg. 2001;136(4):376-382. doi:10.1001/archsurg.136.4.376.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Subscribe to the journal
Related JAMA Surgery Collections
From The JAMA Network
JAMA Neurology
Editorial  | 
Is No Evidence of Disease Activity a Realistic Goal for Patients With Multiple Sclerosis?
Jaime Imitola, MD; Michael K. Racke, MD
JAMA Neurology
Original Investigation  | 
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort
Dalia L. Rotstein, MD; Brian C. Healy, PhD; Muhammad T. Malik, MD; et al.
JAMA Neurology
Original Investigation  | 
Vaccines and the Risk of Multiple Sclerosis and Other Central Nervous System Demyelinating Diseases
Annette Langer-Gould, MD, PhD; Lei Qian, PhD; Sara Y. Tartof, PhD; et al.
JAMA Neurology
Original Investigation  | 
Association of Cerebrospinal Fluid Levels of Lateral Olfactory Tract Usher Substance (LOTUS) With Disease Activity in Multiple Sclerosis
Keita Takahashi, MD; Yuji Kurihara, PhD; Yume Suzuki, MD, PhD; et al.